Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

A new study published in the Journal of American Medical Association showed that dupilumab (Dupixent), used for treating ...

"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

Regeneron’s first quarter was marked by a negative market reaction, as revenue and non-GAAP earnings fell short of Wall ...

The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...